EIPICO produces more than 300 products covering 23 therapeutic groups including all known pharmaceutical forms either traditional or non-traditional dosage forms such as the soft gelatin, capsules, spansules, lyophilized products, gels, sprayers and effervescent tablets. EIPICO was established as a private investment company in 1980 and started production in 1985. EIPICO typically applies c.G.M.P. Regulations throughout the operational departments including evaluation of raw materials, calibration of equipments, control, holding and distribution of finished products. EIPICO plant has a U-shaped design that minimizes mix-up and/or contamination by providing a single direction of material flow and is also surrounded by a green area as a protection from surrounding environment. Each pharmaceutical process has enough space to be carried out apart to minimize mix-up and/or cross contamination. EIPICO is unique by its Sterile Areas (which are the largest in the Middle East and North African Region) that are environmentally controlled to obtain filtered air up to 97% - 99.7% particulate-free. The water purification system in EIPICO was designed to supply the production zones with dematerialized and distilled water. EIPICO was the Pioneer Egyptian Company to produce dosage forms like the spansule capsules (long-acting). EIPICO also produces the non-traditional dosage forms such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. The sound management enables EIPICO to seek the highest quality of raw material from the least expensive sources.